Randomized Crossover Study to Test the Impact of Using a Software for Smartphones and Tablets in Treating Type 1 Diabetes
Primary Purpose
Type 1 Diabetes, Quality of Life, Hypoglycaemia
Status
Completed
Phase
Not Applicable
Locations
Switzerland
Study Type
Interventional
Intervention
Webdia Software
Sponsored by
About this trial
This is an interventional treatment trial for Type 1 Diabetes focused on measuring Type 1 diabetes, HbA1C, Quality of Life, Hypoglycaemia, Self-management, Telemedicine
Eligibility Criteria
Inclusion Criteria:
- Age 10 - 18 years
- Type 1 diabetes mellitus with positive auto-antibodies against Islet Antigen (IA) 2, insulin, islets, Glutamic Acid Decarboxylase (GAD) 65 or Zink
- Disease duration equal or more than 6 months
- Treatment by subcutaneous insulin: by multiple daily injections of pump therapy
Exclusion Criteria:
- Previous use of Webdia Software
- Absence of hardware necessary to install the Webdia Software
Sites / Locations
- University Hospital of Geneva
Arms of the Study
Arm 1
Arm 2
Arm Type
Experimental
No Intervention
Arm Label
Webdia Software use
Observation
Arm Description
Use of Webdia Software during 3 months by the patient. Monthly review of blood glucose values by the medical team and automatic adjustment of insulin doses by the team.
No use of the software. No intervention.
Outcomes
Primary Outcome Measures
Effect of Webdia Software use on HbA1C
Secondary Outcome Measures
Effect of Webdia Software use on quality of life
Quality of life assessment by the use of the Diabetes Quality of Life for Youths (DQOLY) questionnaire published by Ingersoll et al. 1991.
Effect of Webdia Software use on the incidence of hypoglycaemic events
Full Information
1. Study Identification
Unique Protocol Identification Number
NCT02107326
Brief Title
Randomized Crossover Study to Test the Impact of Using a Software for Smartphones and Tablets in Treating Type 1 Diabetes
Official Title
Webdia Study: Use of Smartphones to Improve Diabetes Control and Quality of Life in Children With Type 1 Diabetes
Study Type
Interventional
2. Study Status
Record Verification Date
October 2017
Overall Recruitment Status
Completed
Study Start Date
May 2014 (undefined)
Primary Completion Date
August 15, 2017 (Actual)
Study Completion Date
October 1, 2017 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor-Investigator
Name of the Sponsor
Philippe Klee
4. Oversight
Data Monitoring Committee
No
5. Study Description
Brief Summary
The purpose of this study is to evaluate the impact of a software for smartphones and tablets on type 1 diabetes control and quality of life
Detailed Description
The hypothesis underlying this project, is that most calculations necessary for flexible intensive insulin therapy for type 1 diabetes in children can be performed using software installed on a smartphone or tablet that nowadays is carried by most parents and children. Smartphones and tablets can easily communicate with each other and with a desktop computer via the Internet, thereby permitting the exchange of information such as blood glucose values or types of meals among family members and physicians. Finally, software collecting blood glucose values and merging values obtained on different devices easily permits reviewing these values by the patient and sending them to the physician's office, thereby avoiding consultations during which no blood glucose values are brought by the patient.
We hypothesize that the Webdia software, that will be tested in this randomized crossover study, will increase treatment compliance and therefore will improve diabetes self-management. We believe, the software will facilitate the adaptation of insulin schemes by physicians and therefore will lead to improved HbA1C values. We also think that this software will improve the patient's quality of life.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Type 1 Diabetes, Quality of Life, Hypoglycaemia
Keywords
Type 1 diabetes, HbA1C, Quality of Life, Hypoglycaemia, Self-management, Telemedicine
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Crossover Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
55 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Webdia Software use
Arm Type
Experimental
Arm Description
Use of Webdia Software during 3 months by the patient. Monthly review of blood glucose values by the medical team and automatic adjustment of insulin doses by the team.
Arm Title
Observation
Arm Type
No Intervention
Arm Description
No use of the software. No intervention.
Intervention Type
Device
Intervention Name(s)
Webdia Software
Primary Outcome Measure Information:
Title
Effect of Webdia Software use on HbA1C
Time Frame
0, 3, 6 and 9 months after inclusion
Secondary Outcome Measure Information:
Title
Effect of Webdia Software use on quality of life
Description
Quality of life assessment by the use of the Diabetes Quality of Life for Youths (DQOLY) questionnaire published by Ingersoll et al. 1991.
Time Frame
0, 3, 6 and 9 months after inclusion
Title
Effect of Webdia Software use on the incidence of hypoglycaemic events
Time Frame
During 2 weeks at the end of the 3-months period of Webdia Software use
10. Eligibility
Sex
All
Minimum Age & Unit of Time
10 Years
Maximum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Age 10 - 18 years
Type 1 diabetes mellitus with positive auto-antibodies against Islet Antigen (IA) 2, insulin, islets, Glutamic Acid Decarboxylase (GAD) 65 or Zink
Disease duration equal or more than 6 months
Treatment by subcutaneous insulin: by multiple daily injections of pump therapy
Exclusion Criteria:
Previous use of Webdia Software
Absence of hardware necessary to install the Webdia Software
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Philippe Klee, MD-PhD
Organizational Affiliation
University Hospital, Geneva
Official's Role
Principal Investigator
Facility Information:
Facility Name
University Hospital of Geneva
City
Geneva
State/Province
GE
ZIP/Postal Code
1211
Country
Switzerland
12. IPD Sharing Statement
Links:
URL
http://www.webdia.ch
Description
Homepage of the Webdia Software being tested in this study
Learn more about this trial
Randomized Crossover Study to Test the Impact of Using a Software for Smartphones and Tablets in Treating Type 1 Diabetes
We'll reach out to this number within 24 hrs